The Representative Office of IBSA in Russia (part of IBSA Group) was established in Moscow in 2015 to respond to unmet medical needs and realise state registration of medicines, food supplements and medical devices. Furthermore, we are developing marketing and commercial projects in Russia with various partners, mainly Big Pharma and other important local pharmaceutical players.
IBSA Russia has successfully performed several clinical trials, and registered different pharmaceutical products and active pharmaceutical ingredients. The Russian Office works also on licensing out projects and GMP (Good Manufacturing Practices) audits of our industrial plants in Italy and Switzerland.
IBSA Russia focuses on the commercialisation of hormones for human reproduction, osteoarticular medicines, uro-gynaecological products and medicines for erectile dysfunction.
The main objective of the company is to be a benchmark for patients and doctors in Russia by implementing pharmaceutical products and innovative administration systems with proven efficacy that significantly improve the quality of the molecules and therapeutic solutions already on the market.
This commitment will contribute to improving the level of healthcare in Russia and to developing efficient therapies to treat illnesses that, although not life-endangering, nevertheless have a major impact on society, both in terms of cost and quality of life.